Programmed Cell Death-1/Programmed Cell Death-1 Ligand as Prognostic Markers of Coronavirus Disease 2019 Severity

Programmed Cell Death-1/Programmed Cell Death-1 Ligand as Prognostic Markers of Coronavirus Disease 2019 Severity

Current research proves that immune dysregulation is a common feature of coronavirus disease 2019 (COVID-19), and immune exhaustion is associated with increased disease mortality. Immune checkpoint molecules, including the programmed cell death-1 (PD-1)/PD-1 ligand (PD-L1) axis, may serve as markers...

Full description

Bibliographic Details
Main Authors: Paulina Niedźwiedzka-Rystwej, Adam Majchrzak, Bogusz Aksak-Wąs, Karol Serwin, Zenon Czajkowski, Ewelina Grywalska, Izabela Korona-Głowniak, Jacek Roliński, Miłosz Parczewski
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cells
Subjects:
immunophenotype
disease severity
severe acute respiratory syndrome coronavirus 2
lymphocyte
programmed cell death protein 1
Online Access:https://www.mdpi.com/2073-4409/11/12/1978

Internet

https://www.mdpi.com/2073-4409/11/12/1978

Similar Items